Pharma Solutions
Expert view: 5 things you need to know about nitrosamines in drug formulation
13 May 2022 | 6 min
We know how important it is to stay up-to-date with the latest news, regulatory updates and results from key clinical trials. This section will keep you at the forefront of recent advances in the pharmaceutical industry, including science-backed therapeutic benefits of vitamin active pharmaceutical ingredients, events and DSM’s latest business developments.
13 May 2022 | 6 min
21 Jan 2022 | 4 min
09 Dec 2021 | 4 min
06 Dec 2021 | 4 min
03 Nov 2021 | 4 min
22 Jul 2021 | 3 min
30 Jun 2021 | 4 min
07 Apr 2021 | 4 min
17 Feb 2021 | 4 min
14 Dec 2020 | 4 min
29 Oct 2020 | 7 min
29 Sep 2020 | 7 min
02 Sep 2020 | 7 min
31 Jul 2020 | 8 min
18 Feb 2020 | 5 min
10 Oct 2018 | 4 min
01 May 2018 | 8 min
23 Apr 2018 | 7 min
26 Feb 2018 | 8 min
Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, announces it has entered into an exclusive commercial partnership with global leader and pioneer in cannabinoid active pharmaceutical ingredients (APIs), Brains Bioceutical.
Stay up-to-date on the latest science, events and market trends
Request samples, place orders and view product documentation
Download the latest copy of our Solutions Catalogue
We’re more than a partner. We’re a competitive edge.
The latest in vitamin and lipid research and industry developments
Academic studies and the latest science in educational modules
Videos exploring the growing role of vitamin APIs and lipid API intermediates
